NKE
36
-6
HP
46
-2
ALL
50
-3
GOOGL
50
-17
INTU
58
-7
TXN
53
-15
BAX
41
-3
MMM
57
-4
WAT
52
-2
SHW
50
-3
NWL
54
-3
TROW
56
-2
LYB
11
-2
DVA
47
-2
QRVO
53
-2
AME
62
-3
CL
54
-4
RCL
59
-3
FE
50
-2
AVGO
33
2
NKE
36
-6
HP
46
-2
ALL
50
-3
GOOGL
50
-17
INTU
58
-7
TXN
53
-15
BAX
41
-3
MMM
57
-4
WAT
52
-2
SHW
50
-3
NWL
54
-3
TROW
56
-2
LYB
11
-2
DVA
47
-2
QRVO
53
-2
AME
62
-3
CL
54
-4
RCL
59
-3
FE
50
-2
AVGO
33
2
Financhill
Back

Gitlab, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
21

GTLB
Gitlab, Inc.

Last Price:
$39.06
Seasonality Move:
4.37%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
21
Gitlab, Inc. (GTLB) is a Sell

Is Gitlab, Inc. a Buy, Sell or Hold?

  • The current Gitlab, Inc. [GTLB] share price is $39.07. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

GTLB Stock Price Chart

What is Gitlab, Inc.'s stock price today?

  • The Gitlab, Inc. share price today is $39.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.03 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 625552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.83 - 46.31) Sell
Bollinger Bands (100): (42.34 - 48.6) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.74 Sell
20-day SMA: 42.12 Sell
50-day SMA: 44.94 Sell
200-day SMA: 46.67 Sell
8-day EMA: 39.55 Sell
20-day EMA: 41.65 Sell
50-day EMA: 43.98 Sell
200-day EMA: 47.44 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Gitlab, Inc. Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Gitlab, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):